Justin Jarred Wilkins - Department of Pharmaceutical Biosciences, Uppsala University

基本信息

Career Trajectory

Bio

I work as a consultant in pharmacometrics for the pharmaceutical industry, and have a strong interest in software development in my area. Most recently I've worked on projects related to immunooncology and malaria.

Research Interests

Papers共 63 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients with Relapsed or Refractory Follicular Lymphoma

Junyi Li, Michael Z Liao,Justin Wilkins,Elicia Penuel,Bei Wang,Shweta Vadhavkar,Kun Peng,Junning Cao,Zhiming Li, Ye Zhang, Wenjin Li, Donghang Li, Mingzhu Zhou, Michael C Wei,Antonia Kwan, Rong Zhao, Chunze Li,Chi-Chung Li,David C Turner

Clinical and translational scienceno. 5 (2025): e70211-e70211

Cited0Views0WOSBibtex

Interplay Between Pharmacokinetics and Immunogenicity of Therapeutic Proteins: Stepwise Development of a Bidirectional Joint Pharmacokinetics-Anti-drug Antibodies Model

Jan-Stefan van der Walt,Justin Wilkins,Akash Khandelwal,Karthik Venkatakrishnan, Wei Gao, Ana-Marija Milenković-Grišić

Journal of Pharmacokinetics and Pharmacodynamicsno. 3 (2025): 1-21

Cited0Views0WOSBibtex

A Novel Step-Up Dosage Regimen for Enhancing the Benefit-to-Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma

Chi-Chung Li,Brendan Bender,Justin Wilkins,Feifei Li,David C. Turner,Bei Wang,Rong Deng,Shweta Vadhavkar,Zao Li,Antonia Kwan, Huang,Kun Peng,Elicia Penuel,Ling-Yuh Huw,Pascal Chanu,Chunze Li,Shen Yin,Michael C. Wei

Clinical pharmacology and therapeuticsno. 2 (2024): 465-474

Cited0Views0WOSBibtex

Covariate Modeling in Pharmacometrics: General Points for Consideration

Kinjal Sanghavi,Jakob Ribbing,James A. Rogers,Mariam A. Ahmed,Mats O. Karlsson,Nick Holford,Estelle Chasseloup,Malidi Ahamadi,Kenneth G. Kowalski,Susan Cole,Essam Kerwash,Janet R. Wade, Chao Liu,Yaning Wang,Mirjam N. Trame,Hao Zhu,Justin J. Wilkins

CPT Pharmacometrics & Systems Pharmacologyno. 5 (2024): 710-728

Cited4Views0WOSBibtex

Semi-mechanistic Population Pharmacokinetic/pharmacodynamic Modeling of a Plasmodium Elongation Factor 2 Inhibitor Cabamiquine for Prevention and Cure of Malaria

Perrine Courlet,Justin J. Wilkins,Claude Oeuvray, Wei Gao,Akash Khandelwal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY（2023）

Cited2Views0WOSBibtex

Leveraging Disease Progression Modeling to Aid Clinical Decision and Optimize Drug Development for Idiopathic Pulmonary Fibrosis (IPF)

Tu Mai,Justin Wilkins,Shweta Vadhavkar, Katerina Samara,Nikhil Kamath,Lin Pan,Joy Hsu

EUROPEAN RESPIRATORY JOURNAL (2023)

Cited0Views0Bibtex

Model-informed Approach for Risk Management of Bleeding Toxicities for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1

Vugmeyster Yulia, Grisic Ana-Marija,Wilkins Justin J.,Loos Anja H., Hallwachs Roland,Osada Motonobu,Venkatakrishnan Karthik,Khandelwal Akash

Cancer Chemotherapy and Pharmacology（2022）

Cited11Views0WOSBibtex

Characterization of Exposure–response Relationships of Ipatasertib in Patients with Metastatic Castration-Resistant Prostate Cancer in the IPATential150 Study

Naoki Kotani,Justin J. Wilkins,Janet R. Wade,Steve Dang,Dhruvitkumar S. Sutaria,Kenta Yoshida,Sameer Sundrani, Hao Ding,Josep Garcia,Heather Hinton,Rucha Sane,Pascal Chanu

Cancer Chemotherapy and Pharmacology（2022）

Cited4Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn